These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15271008)

  • 1. Excessive increase in QT interval and dispersion of repolarization predict recurrent ventricular tachyarrhythmia after amiodarone.
    Aiba T; Shimizu W; Inagaki M; Satomi K; Taguchi A; Kurita T; Suyama K; Aihara N; Sunagawa K; Kamakura S
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):901-9. PubMed ID: 15271008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
    Letsas KP; Weber R; Astheimer K; Kalusche D; Arentz T
    Europace; 2010 Feb; 12(2):271-4. PubMed ID: 19897501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Iacoviello M; Forleo C; Guida P; Romito R; Sorgente A; Sorrentino S; Catucci S; Mastropasqua F; Pitzalis M
    J Am Coll Cardiol; 2007 Jul; 50(3):225-31. PubMed ID: 17631214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia.
    Kotake Y; Kurita T; Akaiwa Y; Yasuoka R; Motoki K; Kobuke K; Iwanaga Y; Miyazaki S
    J Cardiol; 2015 Aug; 66(2):161-7. PubMed ID: 25468767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of determination of QT dispersal intervals in anti-arrhythmia therapy].
    Konecná P; Dvorák R; Semrád B
    Vnitr Lek; 1999 Aug; 45(8):453-6. PubMed ID: 11045143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of nifekalant hydrochloride on the QT dispersion after direct-current defibrillation.
    Maeda K; Takagi M; Tatsumi H; Nakagawa E; Yoshiyama M
    Osaka City Med J; 2008 Jun; 54(1):11-9. PubMed ID: 18819261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive factors of induction of ventricular arrhythmia under amiodarone].
    Bourret N; Kirkorian G; Chevalier P; Bellon C; Richalet C; Bouchayer D; Bonnefoy E; Touboul P
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1277-81. PubMed ID: 8952825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of amiodarone on QT dispersion in the 12-lead standard electrocardiogram and its significance for subsequent arrhythmic events.
    Grimm W; Steder U; Menz V; Hoffmann J; Maisch B
    Clin Cardiol; 1997 Feb; 20(2):107-10. PubMed ID: 9034638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of life-threatening ventricular tachyarrhythmia by a novel and pure class-III agent, nifekalant hydrochloride.
    Ohashi J; Yasuda S; Miyazaki S; Shimizu W; Morii I; Kurita T; Kawamura A; Kamakura S; Nonogi H
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):274-9. PubMed ID: 17204905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome.
    Meierhenrich R; Helguera ME; Kidwell GA; Tebbe U
    Int J Cardiol; 1997 Aug; 60(3):289-94. PubMed ID: 9261640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-dependent effect of cardiac resynchronization therapy on ventricular repolarization and ventricular arrhythmias.
    Itoh M; Yoshida A; Fukuzawa K; Kiuchi K; Imamura K; Fujiwara R; Suzuki A; Nakanishi T; Yamashita S; Matsumoto A; Hirata K
    Europace; 2013 Dec; 15(12):1798-804. PubMed ID: 23736809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplified transmural dispersion of repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge model of short-QT syndrome.
    Extramiana F; Antzelevitch C
    Circulation; 2004 Dec; 110(24):3661-6. PubMed ID: 15569843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Haigney MC; Zareba W; Gentlesk PJ; Goldstein RE; Illovsky M; McNitt S; Andrews ML; Moss AJ;
    J Am Coll Cardiol; 2004 Oct; 44(7):1481-7. PubMed ID: 15464332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
    Marill KA; deSouza IS; Nishijima DK; Senecal EL; Setnik GS; Stair TO; Ruskin JN; Ellinor PT
    Acad Emerg Med; 2010 Mar; 17(3):297-306. PubMed ID: 20370763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of ventricular tachyarrhythmias by intracardiac repolarization variability analysis.
    Tereshchenko LG; Fetics BJ; Domitrovich PP; Lindsay BD; Berger RD
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):276-84. PubMed ID: 19808478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone-induced QT prolongation in a newly transplanted heart associated with recurrent ventricular fibrillation.
    Schwarz ER; Czer LS; Simsir SA; Kass RM; Trento A
    Cardiovasc J Afr; 2010; 21(2):109-12. PubMed ID: 20532436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia.
    Shiga T; Tanaka K; Kato R; Amino M; Matsudo Y; Honda T; Sagara K; Takahashi A; Katoh T; Urashima M; Ogawa S; Takano T; Kasanuki H;
    Resuscitation; 2010 Jan; 81(1):47-52. PubMed ID: 19913983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.